Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07449091

Adaptability of an Undetectable = Untransmissible Model for HBV

Adaptability of an Undetectable = Untransmissible Model for HBV: Are Suppressed Viral Levels in the Serum Consistent Across Body Fluid Reservoirs?

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fear of transmission to their partners leading to social isolation and impact on their personal lives. This study will provide data correlating serum and body fluid viral levels in persons with chronic hepatitis B infection not on therapy and those with viral suppression on long-term anti-retroviral therapy (ART) that may support the concept of "Undetectable=Untransmissible" (U=U) in patients with chronic hepatitis B.

Conditions

Timeline

Start date
2026-03-01
Primary completion
2027-09-01
Completion
2027-09-01
First posted
2026-03-04
Last updated
2026-03-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07449091. Inclusion in this directory is not an endorsement.

Adaptability of an Undetectable = Untransmissible Model for HBV (NCT07449091) · Clinical Trials Directory